Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes

Publication Description
AIM: To examine concentrations of biomarkers (adiponectin, C-reactive protein, fibrinogen and tissue plasminogen-activator antigen) associated with glucose homeostasis and diabetes risk by history of gestational diabetes. METHODS: We conducted a secondary analysis of the Diabetes Prevention Program, a randomized trial of lifestyle intervention or metformin for diabetes prevention. At baseline, participants were overweight and had impaired glucose tolerance. Biomarkers at baseline and 1 year after enrolment were compared between parous women with (n=350) and without a history of gestational diabetes (n=1466). Cox proportional hazard models evaluated whether history of gestational diabetes was associated with diabetes risk, after adjustment for baseline biomarker levels as well as for change in biomarker levels, demographic factors and anthropometrics. RESULTS: At baseline, women with histories of gestational diabetes had lower adiponectin (7.5 mug/ml vs. 8.7 mug/ml; p<0.0001) and greater log C-reactive protein (-0.90 mg/l vs. -0.78 mg/l, p=0.04) levels than women without histories of gestational diabetes, but these associations did not persist after adjustment for demographic factors. Fibrinogen and tissue plasminogen-activator antigen were similar between women with and without histories of gestational diabetes. Women with and without histories of gestational diabetes had a similar pattern of changes in biomarkers within randomization arm. Adjustment for age, race/ethnicity, baseline weight, change in weight, baseline biomarker level and change in biomarker level did not significantly alter the association between history of gestational diabetes and diabetes risk. CONCLUSIONS: Among women with impaired glucose tolerance, biomarkers in women with and without histories of gestational diabetes are similar and respond similarly to lifestyle changes and metformin. Adjustment for biomarker levels did not explain the higher risk of diabetes observed in women with histories of gestational diabetes. This article is protected by copyright. All rights reserved.

Primary Author
Kim,C.
Christophi,C. A.
Goldberg,R. B.
Perreault,L.
Dabelea,D.
Marcovina,S. M.
Pi-Sunyer,X.
Barrett-Connor,E.

Author Address
Departments of Medicine and Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI.; Biostatistics Center, George Washington University, Rockville, MD.; Department of Medicine, University of Miami, Miami, FL.; Department of Medicine, U(TRUNCATED)

Volume
33

Issue
1

Start Page
32

Other Pages
8

Author Address
Departments of Medicine and Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI.; Biostatistics Center, George Washington University, Rockville, MD.; Department of Medicine, University of Miami, Miami, FL.; Department of Medicine, U(TRUNCATED)

URL
http://www.ncbi.nlm.nih.gov/pubmed/25970741?dopt=abstract

PMID
25970741

PMCID
PMC4644121



Reference Type
Journal Article

Periodical Full
Diabetic medicine : a journal of the British Diabetic Association

Publication Year
2015

Publication Date
13-May

ISSN/ISBN
1464-5491

Document Object Index
10.1111/dme.12799 [doi]

Accession Number
PMID: 25970741